Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-25 @ 1:49 PM
Study NCT ID:
NCT03546192
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2018-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-17
Start Date Type:
None
Primary Completion Date:
2015-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-22
First Submit QC Date:
None
Study First Post Date:
2018-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2018-07-06
Results First Submit QC Date:
None
Results First Post Date:
2018-08-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-29
Last Update Post Date Type:
ACTUAL